New Zealand to vote on legalization of recreational marijuana

CGTN 22 August 2020
Our additional comment: SayNopeToDope campaign and spokesman Aaron Ironside are included in the coverage of the referendum by China Global Television Network.
International interest!

Voters in New Zealand this year will decide whether to legalize recreational marijuana. Under the proposal, cannabis would be grown and sold by licensed businesses and will be taxed. The possession and use of cannabis has been a crime in New Zealand since 1961. Public opinion is evenly divided on the legalization issue, but those who’re campaigning against it blame it for mental health issues and family violence. The proposed law limits potency of cannabis, smoking in public is banned, and teenagers can’t legally buy it. Sales taxes will also be spent on health and education programs, but opponents say that doesn’t justify legalization. And if a majority vote Yes, and if the present Labour government is re-elected as polls suggest, the drug could be legal within 18 months.
https://news.cgtn.com/news/2020-08-22/New-Zealand-to-vote-on-legalization-of-recreational-marijuana-TavxEJ5fna/index.html
twitter follow us

Cannabis referendum: This is about recreational use, not medicinal treatment

Stuff co.nz 24 August 2020
Family First Comment: Ouch! The smokescreen of the Drug Foundation and Chloe are destroyed by this good doctor….
So many good statements that it’s hard to know which bit to highlight!
“Suggesting that voting yes for recreational cannabis will mean better access for medicinal treatment is misleading at worst and disingenuous at best…. As a GP I feel a duty to help ensure the public is properly informed when they cast their vote, they should know about the existing availability of medicinal cannabis and the potential risks of self-prescribing cannabis for health reasons. I’m concerned that many voters have been led to believe a cannabis referendum ‘Yes vote’ equals a ‘Yes’ for medicinal cannabis. This is not the case; patients already have access to medicinal cannabis. It’s legal under the Medicinal Cannabis Scheme and currently available via prescription from doctors who can identify any potential drug interactions and adverse effects that may affect a patient.”
“Admissions to psychiatric hospitals for marijuana induced psychosis will go through the roof. Over the last few years we’ve put millions of dollars into the prevention and treatment of mental illness. Speak to any health professional that works in this field and they’ll tell you the impact that marijuana has on psychosis. Increasing access will undoubtedly result in a surge in mental health admissions. Smoking cannabis comes with the same risk of lung damage as smoking cigarettes and let’s remember New Zealand has made a commitment to be smokefree by 2025.”
#VoteNopeToDope

OPINION: Suggesting that voting yes for recreational cannabis will mean better access for medicinal treatment is misleading at worst and disingenuous at best.

With the cannabis referendum fast approaching, arguments for and against the legalisation of cannabis for recreational use are being put forward by numerous interested parties.

As a GP I feel a duty to help ensure the public is properly informed when they cast their vote, they should know about the existing availability of medicinal cannabis and the potential risks of self-prescribing cannabis for health reasons.

I’m concerned that many voters have been led to believe a cannabis referendum ‘Yes vote’ equals a ‘Yes’ for medicinal cannabis. This is not the case; patients already have access to medicinal cannabis. It’s legal under the Medicinal Cannabis Scheme and currently available via prescription from doctors who can identify any potential drug interactions and adverse effects that may affect a patient.

Should recreational cannabis be legalised it may become more commercially viable for local companies to also enter the medicinal cannabis market, however this is not a given. The Ministry of Health has set stringent requirements for the approval of new medicinal cannabis products and no new applications have been made to date.

However, the public should be aware that legalising cannabis for recreational use isn’t a guarantee of better access to safe, tested and approved cannabis products for medicinal treatment.

Dr Mark Hotu is a GP and medicinal cannabis specialist at the Green Doctors clinic.
READ MORE: https://www.stuff.co.nz/national/cannabis-referendum/122437472/cannabis-referendum-this-is-about-recreational-use-not-medicinal-treatment

facebook_icon

Mixed reaction to King’s rector’s drug post

Otago Daily Times 22 August 2020
Family First Comment: Yes! Well said Nick McIvor.
From someone who cares for our children…
“King’s High School rector Nick McIvor has spoken out over his worries about what could happen in education if non-medical cannnabis is legalised.
“We could be drifting towards something to the detriment of our young people; something that will be deeply regretted in future,””

King’s High School rector Nick McIvor has spoken out over his worries about what could happen in education if non-medical cannnabis is legalised.

“We could be drifting towards something to the detriment of our young people; something that will be deeply regretted in future,” Mr McIvor, said in a message on the school’s official Facebook page.

Mr McIvor acknowledged a range of views for and against legalisation in the lead-up to the referendum, but said he was “struggling to see how legalisation would improve the lives of young people in New Zealand”.

” I fear that it would make them worse,” he said in his Friday evening message.

Several of more than 130 people who responded to his comments supported his views, and one person said it had taken “a lot of courage” to speak out, and this was appropriate from a school principal.

However, many people took issue with his comments and several strongly questioned the appropriateness of using the school’s official Facebook site to give a personal view.
READ MORE: https://www.odt.co.nz/news/dunedin/mixed-reaction-kings-rectors-drug-post

signup-rollKeep up with family issues in NZ.
Receive our weekly emails direct to your Inbox.

Think Ya Know? Is Marijuana a Gateway Drug?

The marijuana lobby gets very upset at any suggestion of marijuana being called a gateway drug. Of course, not everyone who starts using marijuana uses other drugs; some just go on to stronger versions of marijuana, such as “wax,” “dabs” or vapes. Others may not use anything stronger than the old-fashioned weed of the last century.

Yet the scientific evidence suggests it is a gateway drug that can open the doors to other addictions, including alcohol: Studies show that marijuana affects dopamine receptors and our brain’s reward system which may lead to the use of many other different drugs. In one study done by the University of Michigan Medical School, researchers found a negative correlation between the amount of marijuana consumed over time and the amount of dopamine that was released in the brain in response. Smokers will then seek other drugs in order to achieve the high they used to experience with pot.

The National Institute on Drug Abuse says cannabinoids are able to decrease the reactivity of brain dopamine reward circuits over time, leaving frequent marijuana users vulnerable to other drug addiction. Additionally, THC promotes an enhanced response to other drugs in the same way that alcohol and nicotine do, which may lead to the progression of more drug addictions that may cause a toxic overdose.

NZ-grown cannabis medicines as early next year after new licence for Helius Therapeutics

NZ Herald 18 August 2020
Our additional comment: “High quality and affordable New Zealand-grown cannabis medicines could be available for patients next year after the country’s largest company in the sector secured a new commercial licence… Helius chief executive Paul Manning said the licence means patients can expect high quality, affordable and NZ-grown cannabis medicines as soon as early next year.”
So why is the Yes side using medicinal as justification for recreational use?
Easy.
They’re desperate to win and will use this smokescreen. Don’t be fooled.
#Itsnotworththerisk

High quality and affordable New Zealand-grown cannabis medicines could be available for patients next year after the country’s largest company in the sector secured a new commercial licence.

While the medicinal cannabis industry may play an important role in the nation’s economic recovery from the Covid-19 pandemic.

The Ministry of Health’s Medicinal Cannabis Agency has granted Helius Therapeutics (Helius) the licence to cultivate and process active cannabis ingredients. The company said it applies to its 8800sq m state-of-the-art medicinal cannabis cultivation and manufacturing facility in East Tamaki.

The New Zealand-owned biotechnology company’s new production facility is one of the largest in the Southern Hemisphere.

In a statement to the Herald, Helius chief executive Paul Manning said the licence means patients can expect high quality, affordable and NZ-grown cannabis medicines as soon as early next year.

The licence allows Helius – the country’s largest licenced producer – to cultivate an unlimited number of cannabis plants, including high THC and CBD cultivars. It will also see a number of proprietary varietals yielding valuable minor cannabinoids at the Auckland site, the company said.
READ MORE: https://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=12357507

facebook_icon

Concerns over cannabis use at work

Otago Daily Times 15 August 2020
Our additional comment: Mr Hardy expects more positive tests to follow cannabis legalisation. “We’ve seen … the data coming out of the US, where they had a 75% increase of positive rates for marijuana. From 5.1% and it went to 8.9% for positive marijuana use, which is a huge [increase].” The big question of impairment was not easy for the drug testers either, Mr Hardy said. “No toxicology can detect impairment. With cannabis it’s a really, really tricky substance. If you look at it, you’ve got what’s called intoxication and then you’ve got what’s called impairment.

When recreational cannabis was legalised in states in the United States, it led to a jump in positive drug tests at the workplace of about 75%. Jacob McSweeny takes a look at how workplaces like forestry and the port will manage if cannabis legalisation gets a ‘‘yes’’ at the coming referendum.

There are major concerns among industries with drug testing regimes that more workers will fail tests if cannabis is legalised later this year.

New Zealanders will decide whether to legalise recreational marijuana at next month’s election.

The testers
If there is a “yes” vote and if the legislation then becomes law, how workplaces measure impairment will be the big question for a lot of employers.

The Drug Detection Agency (TDDA) is one of the go-to drug testers for many companies that have to test for health and safety reasons.

TDDA chief executive Kirk Hardy says on average their testing in New Zealand has a positive rate for cannabis of about 5.8%.

For pre-employment tests the average is lower, at about 4%.

Cannabis is king in Otago, as the most common drug found in people’s systems, followed by methamphetamine and opiates.

Mr Hardy expects more positive tests to follow cannabis legalisation.

“We’ve seen … the data coming out of the US, where they had a 75% increase of positive rates for marijuana.

“From 5.1% and it went to 8.9% for positive marijuana use, which is a huge [increase].”

The big question of impairment was not easy for the drug testers either, Mr Hardy said.

“No toxicology can detect impairment.

“With cannabis it’s a really, really tricky substance. If you look at it, you’ve got what’s called intoxication and then you’ve got what’s called impairment.

“Intoxication is when you’re high. The best way to describe it is the analogy of alcohol. You drink alcohol, you’re feeling pretty happy — you’re intoxicated by it. The next day you get what’s called a hangover … you’re impaired.

“You’re impaired during intoxication and you’re impaired after that in the hangover effect.

“Exactly the same thing applies to cannabis.”

He warns some studies have shown impairment can last for weeks after smoking cannabis.

But if someone is only dabbling in a little cannabis on the weekend, it will probably not show up in a test on the following Monday.

“If someone’s having … a couple of tokes of a joint on a Friday or a Saturday night, they are more than likely going to test negative in the workplace on Monday through urine analysis.

“They will definitely test negative with oral fluid, or saliva testing,” he said.

The Drug Foundation
The Drug Foundation executive director Ross Bell described testing for impairment as a “weakness”.

“There isn’t good technology available to workplaces at the moment around measuring impairment.”

Somebody might smoke cannabis on the weekend and pass a Monday test, but, they might also fail that Monday test a few weeks later, Mr Bell said.

“The only testing regime are urine tests, which test for presence. Someone could have smoked five weeks ago and still fail a test.”

He said the current testing regime was inadequate but there was potential with saliva testing.

“Because that tests for more recent use, within the last few hours, that could be a system.”

He had his reservations about that, as well.

“I can’t see a workplace, that even if there was saliva technology, that every morning … you’re going to get all of your 100, 200 or 300 staff to do a saliva test.”

His advice is to work on a culture of understanding around drug use and how it may affect performance.

“Don’t just rely on building a testing regime. Rely on building a culture, a culture that says don’t come to work if you’re impaired, whether you’re hungover or tired or stressed … if you’re not in the right state of mind, don’t come to work.”

He said employers needed to communicate why they needed systems like drug testing.

“We’ve done work with the Defence Force where they had this zero-tolerance approach and staff didn’t really understand what that meant.

“They had never communicated the rationale for taking a strong approach. Workplaces need to educate their staff: ‘we care about you, we want you to stay staff, we want you to look after your workmates, you’re in a risky environment — this is why we can’t have you showing up with your performance impaired’.”

Overall, drug testing sent a bad message to workers and a culture of safety was always a better way to manage drug use, he said.

“There’s a real weakness with drug testing, not just in the technology but in the message it sends to workers: ‘we don’t trust you, we need you to pee in this cup and we’re going to catch you out’.

“That doesn’t make for a good working relationship between employer and employees.”

He said the cannabis referendum was a good chance to engage with staff on the issue, to try to build that safety culture.
READ MORE: https://www.odt.co.nz/business/concerns-over-cannabis-use-work

signup-rollKeep up with family issues in NZ.
Receive our weekly emails direct to your Inbox.

James Farmer QC: Cannabis Legal Reform – Arguments For And Against

James Farmer Q.C. 13 August 2020
Our additional comment: Excellent legal commentary on the possibility of legalising cannabis for recreational use. Rebuts the arguments used by drug advocates:
* cannabis is no more harmful than alcohol and it is legal to consume alcohol and so it should be too for cannabis
* medicinal cannabis is now legal and so cannabis for recreational use should be also
* the legalisation of cannabis use will decrease any harm to users because its production, supply, strength and price will be regulated
* legalisation of cannabis supply and use will eliminate the black market
*it is wrong that people using cannabis should be convicted under the criminal law
He concludes:
A health-focused solution, but via the deterrence and incentivisation (to seek assistance) of the criminal law, is in fact available now in new zealand, a fact that scarcely rates a mention in the current public debate leading up to the referendum.

I have consistently believed that cannabis is a harmful substance and that people who use it for “recreational purposes” would be more sensible to choose a healthy form of recreation that doesn’t put them and those dependent on them, i.e. their children and future children, at risk of harm.

A disappointing feature of the forthcoming cannabis reform referendum (apart from the fact that it’s being held at all) is that it is the consequence of a political deal between the Labour and Green Parties.  Another feature of dubious morality is that it is being promoted as a measure that will generate tax revenues that can be used, as the proposed Cannabis Legislation and Control Bill says, “to reduce the harms associated with cannabis use experienced by individual, families, whanau, and communities in New Zealand”.   Assuming the Bill is successful in achieving its objectives of eliminating the (non-tax-paying) black market – as to which, see below – and that legal cannabis becomes more readily available, the happy equilibrium will be attained of greater access to cannabis, more people using it, more people affected by its harmful effects and more public money to address those effects.

With the referendum now only weeks away, it is a useful time to collect together the arguments for legalization and test their soundness.  The arguments, as they appear to be, are:

(1)    Cannabis is no more harmful than alcohol and it is legal to consume alcohol and so it should be too for cannabis.

(2)    Medicinal cannabis is now legal and cannabis for recreational use should be also.

(3)    The legalisation of cannabis will decrease any harm to users because its production, supply, strength and price will be regulated.

(4)    Legalisation of cannabis supply and use will eliminate the black market.

(5)    It is wrong that people who use cannabis should be convicted under the criminal law.

My analysis, by reference to research, written expert and professional opinion, and plain logic suggests that there are flaws with each of these propositions.  My conclusion is that, properly used, the amendment that was made to the Misuse of Drugs Act 1975 last year that gives Police discretion not to prosecute where a health-centred or therapeutic approach can be achieved is more likely to achieve the proposed Bill’s objective of reducing harm from cannabis use than wholesale legalisation of the use of the drug.
READ MORE: http://www.jamesfarmerqc.co.nz/legal-commentary/cannabis-legal-reform-arguments-for-and-against
twitter follow us

Illegality Keeps Cannabis Use Low & Decreasing – Youth’19

Media Release 14 August 2020
The SayNopetoDope campaign says that new data from Youth19 Rangatahi Smart Survey has confirmed that the illegal status of cannabis is keeping young people from experimenting with cannabis in the first place, that students progressing to ongoing and regular cannabis use is very low, but that legalising it would reverse these gains.

While just 23% of students reported ever using marijuana – dropping from 38% in 2001 – only 4.1% were consuming it on a regular basis, much lower than in 2001 when it was 6.5%. The report says that most students do not use marijuana or other drugs. Maori use marijuana on a regular basis at a higher rate (8.5%) than Pakeha (3.3%) and Pacific use (3.6%). However, even Maori rates have dropped from a high figure of 13.9% in 2001. Asian youth use is low.

In contrast, 22% reported binge drinking in the past month, and remains high compared with other countries.

Research published 12 months ago in the New Zealand Medical Journal has shown a long-term decline in the number of secondary school students’ “lifetime cannabis use”, and the proportion using cannabis weekly (or more often) halving. Commentators say that cannabis use among teens is dropping thanks to changing attitudes towards ‘risky behaviours’.

According to the Royal Society Te Aparangi 2019 report, marijuana use, particularly frequent use starting from a young age, can harm mental health and have other negative effects.

“The researchers in this latest study correctly state that ‘there are factors that more directly address substance use and addictive behaviours such as ensuring harmful substances are not available in communities, and adults role modelling healthy choices and not supplying substances’. Legalisation will undo all this great progress by normalising drug use and making it more available and more evident in communities,” says spokesperson Aaron Ironside.

“We support a health-based approach where young users are discouraged from usage and sent a clear societal message that they should be drug-free, while also offering counselling and addiction services to assist them away from drug use. Sometimes this will involve the stigma and coercion of the law.”

These New Zealand stats come at the same time as the state of Colorado has found that marijuana use has skyrocketed in the last two years with nearly 21% of young people in the state reporting past month use. Notably, use in young teens (aged 15 and younger) has increased 15.5% from 2017 (the last time data was collected).

According to the data, part of the Healthy Kids Colorado Survey, since 2017, past month marijuana use among those aged 15 or younger has increased 14.8%, 16 or 17-year-olds has increased 3.0%, and 18 or older has increased 1.9%. Overall, marijuana use amongst all age groups has risen 6.2%.

In a disturbing development, teens report an alarming increase in their use of ultra-potent pot products in the form of dabs and vapes. More than half of high school students (52%) who use marijuana reported that they dab marijuana to get high – up from 34.4% just two years ago.

In addition to highlighting the increases in dabbing and vaping, the Colorado Department of Public Health and Environment noted that the percentage of youth who drove after using marijuana more than tripled in two years.  And in states where recreational marijuana has been legalised, teenagers are suffering higher rates of addiction.

The Substance Abuse and Mental Health Services Administration (SAMHSA) released the 2017-2018 National Survey on Drug Use and Health (NSDUH) State Estimates in December 2019, and found that past year and past month marijuana use among 12 to 17 year-olds in “legal” states increased around 3.5%, each from 2016-2017 to 2017-2018.

 

Systematic review uncovers cannabis withdrawal syndrome among 47% of regular cannabis users

PsyPost 11 August 2020
Our additional comment: More harms – which will increase with legalisation…
“The findings suggest that almost half of regular marijuana users will experience cannabis withdrawal, something the authors say many people are unaware of. Cannabis withdrawal appears to be highly prevalent among people who consume cannabis regularly, or who are heavy consumers. Clinicians should be aware of its existence so that they can provide support to people who are considering cessation of or reduction in cannabis use. The literature suggests that cannabis withdrawal may be a driver of continued use…”

A literature review of 47 studies found that nearly half of cannabis users met criteria for cannabis withdrawal syndrome. The review was published in The Journal of the American Medical Association.

Although cannabis is typically seen as a relatively safe drug, research has pointed to various risks associated with regular use. Short-term risks include memory impairment and paranoia and long-term risks range from addiction and cognitive impairment to suicide. More recently, researchers have identified the presence of cannabis withdrawal syndrome (CWS) in a subset of regular users.

Despite the emerging evidence of CWS, little is known about the prevalence or risk factors associated with its occurrence. “Cannabis withdrawal is a fascinating topic. We were not certain on the prevalence or risk factors for cannabis withdrawal, which was the basis of the study,” said study author Anees Bahji, an addiction psychiatry fellow at the University of Calgary.

The researchers consulted 8 electronic databases and ended up with 47 studies that met criteria to be included in their review. All studies included a validated assessment of CWS or CWS symptoms. In total, the studies involved 23,518 participants, 69% of whom were men. The studies involved 50 different cohorts; half of them were users seeking treatment and most (76%) were from North America.

The meta-analysis revealed an overall prevalence of cannabis withdrawal syndrome of 47%. The researchers further analyzed the results by study setting, to see if the likelihood of CWS differed depending on the sample used in the study. The highest prevalence of CWS (87%) was found in inpatient samples. Outpatient samples had a prevalence of 54% and population-based samples had a 17% prevalence of CWS.

“The finding that the prevalence of CWS was substantially higher in clinical populations—particularly inpatient samples—is consistent with the notion of a bidirectional association between cannabis use and mental health disorders . . . This finding may indicate that people with CWS are more likely to present to clinicians for help compared with those without CWS, notwithstanding the fact that CWS can be diagnosed and untreated,” Bahji and colleagues say.
READ MORE: https://www.psypost.org/2020/08/systematic-review-uncovers-cannabis-withdrawal-syndrome-among-47-of-regular-cannabis-users-57641

facebook_icon

Cannabis: What are the risks of recreational use?

BBC News 19 June 2018
The government has said there will be a review into the use of cannabis for medicinal purposes but has rejected suggestions by former Foreign Secretary Lord Hague that its recreational use could be legalised.

Home Secretary Sajid Javid said there was strong scientific evidence the drug could “harm people’s mental and physical health and damage communities”.

What do experts think about the health risks of recreational cannabis use?
Cannabis is thought to be the most widely used illegal drug in the UK.

But while it can lead to feelings of relaxation, happiness and sleepiness, many experts say the drug is not the harmless “natural” high some claim it to be.

In some cases, it can increase anxiety and paranoia, lead to confusion and even hallucinations, according to the Royal College of Psychiatrists.

Beyond this, there’s also “compelling evidence” that regular cannabis use increases the risk of developing psychotic illnesses, such as schizophrenia, particularly in adolescents, says Dr Marta di Forti, from King’s College London.

Younger people are thought to be particularly vulnerable because their brains are still developing, says Dr Michael Bloomfield, from University College London.

Studies have linked the increased risk of psychosis to potent strains of cannabis that have higher proportions of the psychoactive compound THC, says Dr Di Forti.

previous study suggested the risk of psychosis was five times higher for people who smoked such cannabis every day compared with non-users.

Milder forms contain less THC and more CBD, which works as an anti-psychotic and counteracts some of the negative effects of THC.

However, research suggests the vast majority of cannabis being sold illegally in the UK is super-strength skunk.

But it’s worth pointing out that the vast majority of people who use cannabis do not develop psychosis and many people diagnosed with such disorders have never used cannabis.

It is also thought that genes may play a role in the risk.

The exact health impact of cannabis use is still a subject of debate, with not all studies reaching the same findings.

Does smoking cannabis cause depression?
While some studies have found an association between regular cannabis use and depression, Dr Di Forti says this link is less clear than that with psychosis.

And it may be the case that people who are depressed are more likely to use cannabis.

Is cannabis addictive?
There was a time when experts thought this was not the case.

But current evidence suggests that it can be – particularly if it’s used regularly – with about 10% of regular users estimated to have a dependence.

For some people who quit, there can be withdrawal symptoms, such as cravings, difficulty sleeping, mood swings, irritability and restlessness, according to the Royal College of Psychiatrists.

“People end up having problems with relationships. It impacts on their ability to function at work and school,” Prof Celia Morgan, professor of psychopharmacology at the University of Exeter, says.

While some of this addiction may be psychological, Dr Bloomfield says there is good evidence to suggest that THC itself can be physically addictive for some people.

“Cannabis addiction exists and it can potentially ruin lives,” he adds.

What about memory?
Getting high on cannabis impairs memory and cognitive ability in the short term, says Prof Morgan.

And some of the effects of this, though mild and reversible, seems to remain for up to 20 days, the amount of time it takes for the drug to leave the system.

Can cannabis be a gateway drug for harder ones, such as cocaine or heroin?
Prof Morgan says that while some people who take hard drugs may also smoke cannabis, there is no strong evidence those who try cannabis will go on to become hard-drug takers.

However, cannabis may lead to a legal drug habit that is harmful in a range of ways – tobacco smoking.

Tobacco is “one of the most damaging addictive substances”, Prof Morgan adds.

What about cancer?
Tobacco smoking is known to increase the risk of a range of illnesses, including cancer and cardiovascular disease.

So does it follow that cannabis smoking also poses the same dangers?

It’s still not clear whether cannabis smoking itself raises the risk of cancer or if the increased risk seen among cannabis smokers is actually the result of them mixing the drug with tobacco.

In any event, people who smoke cannabis regularly, with or without tobacco, are more likely to have bronchitis – inflammation of the lining of the lungs – according to the NHS.

Are there any health benefits?
Many patients who have been self-medicating with recreational cannabis say it works for them.

Recently, the families of 12-year-old Billy Caldwell and six-year-old Alfie Dingley have made newspaper headlines. They say cannabis oil treatments have radically controlled the boys’ epileptic seizures.

While these cannabis oils are not recreational drugs, they’re not medically licensed treatments either.

A cross-party report found good evidence that cannabis treatments can help alleviate the symptoms of chronic pain, multiple sclerosis, nausea and vomiting, particularly in the context of chemotherapy, and anxiety.

It also found moderate evidence it could help with sleep disorders, poor appetite, fibromyalgia, post-traumatic stress disorder and Parkinson’s symptoms.

Now, a government review will look at the evidence and make its own recommendations on which cannabis-based medicines might offer real medical and therapeutic benefits to patients.

But regardless of what they find, Mr Javid added: “This step is in no way a first step to the legalisation of cannabis for recreational use.”
https://www.bbc.com/news/health-44532417

signup-rollKeep up with family issues in NZ.
Receive our weekly emails direct to your Inbox.